As health reform brings a focus on the budget for Medicare, a little-known but influential group with links to the AMA and specialty societies is getting a closer look. It's called the Relative Value Scale Update Committee and it is at the center of a debate over whether doctors have too much control over the flow of taxpayer dollars in the Medicare program. Dr. Barbara Levy, chair of the RUC tells Bruce Japsen about how this group works and the importance of what it does. In a previous segment, he spoke with Tom Scully, senior counsel in Alston & Bird, LLP, in Washington, DC, and former head of the Centers for Medicare & Medicaid Services, about the other side of this debate.
An AMA Perspective on the Relative Value Scale Update Committee

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
As health reform brings a focus on the budget for Medicare, a little-known but influential group with links to the AMA and specialty societies is getting a closer look. It's called the Relative Value Scale Update Committee and it is at the center of a debate over whether doctors have too much control over the flow of taxpayer dollars in the Medicare program. Dr. Barbara Levy, chair of the RUC tells Bruce Japsen about how this group works and the importance of what it does. In a previous segment, he spoke with Tom Scully, senior counsel in Alston & Bird, LLP, in Washington, DC, and former head of the Centers for Medicare & Medicaid Services, about the other side of this debate.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Improving Adherence to CRC Screening: A Primary Care Physician’s Guide
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Impact of Barostim on Heart Failure Hospitalization
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?